Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS

3.32 Up 0.02(0.61%) May 17, 4:00PM EDT|After Hours : 3.32 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 29, 2012Sep 29, 2011Sep 29, 2010
Total Revenue 41,275   10,496   2,895  
Cost of Revenue2,120  446  198  
Gross Profit 39,155   10,050   2,698  
Operating Expenses
Research Development23,066  15,254  13,322  
Selling General and Administrative74,491  55,426  16,473  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (58,402) (60,629) (27,097)
Income from Continuing Operations
Total Other Income/Expenses Net47  1  406  
Earnings Before Interest And Taxes(58,355)(60,628)(26,691)
Interest Expense1,385   -   -  
Income Before Tax(59,741)(60,628)(26,691)
Income Tax Expense3  3  3  
Minority Interest -   -   -  
Net Income From Continuing Ops(59,744)(60,632)(26,694)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (59,744) (60,632) (26,694)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (59,744) (60,632) (26,694)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.